Home Overview Press Room Blog Publications For Students about us
Search

About Assisted Reproduction


Most assisted reproductive technologies (ART) are used to treat infertility. Others are used when there are no fertility problems. Embryo screening or pre-implantation genetic diagnosis, for example, is used in order to prevent the births of children with specific genetic characteristics.

In vitro fertilization (IVF) refers to assisted reproduction procedures in which sperm and eggs are joined outside a woman's body. Women undergoing IVF are given hormonal drugs to promote the development of multiple eggs, which are retrieved with a minor surgical procedure. The eggs are mixed with sperm; one or more of those that fertilize are then transferred to the woman's uterus.

IVF has been in use since 1978 and has resulted in almost four million births worldwide. A number of IVF-related techniques have been introduced since then. Some of these, such as pre-implantation genetic diagnosis and commercial gestational surrogacy, raise significant ethical and policy concerns. In the United States alone, the assisted reproduction business is estimated to create over $3 billion in revenues a year.

Research on the risks associated with ART is notoriously inadequate. There have been few follow-up studies either on women who have used ARTs or their children. The United States is also known for having few laws governing assisted reproduction and little oversight of ART facilities.



The Supreme Court decision that's shaking up biotechby Damian GardeSTATJune 27th, 2016A lower court's decision will stand: Sequenom can't patent its prenatal gene test because it is based on a natural biological process.
Bill covering in vitro fertilization for injured veterans clears the House by Seattle Times StaffThe Seattle TimesJune 23rd, 2016Veterans Affairs is closer to paying for in vitro fertilization for injured soldiers seeking to have children.
Book Review: Discounted Life - The Price of Global Surrogacy in Indiaby ňlo LuikBioNewsJune 20th, 2016Rudrappa locates surrogacy within the histories of politics and control as well as aspiration, nationalism and modernisation that the bodies of working-class Indian women have long been subjects of and subjected to.
DIY sperm test to hit the market this fallby Meghana KeshavanSTAT NewsJune 20th, 2016The semen centrifuge will calculate sperm count, but not sperm motility or other factors that affect fertility.
Do women who donate their eggs run a health risk?by Sandra G. BoodmanThe Washington PostJune 20th, 2016Health advocates say that donors are being falsely reassured that the process is safe, without being told that there is no definitive research.
Japanese city backs egg-freezing scheme to boost birthrate by Associated Press [Urayasu, Japan]The Guardian June 20th, 2016The city of Urayasu is allocating £600,000 for a project in which women will receive a substantial discount to freeze their eggs.
Subsidised egg freezing isnít the answer to Japanís birth rateby Angel PetropanagosNew ScientistJune 17th, 2016The health risks of egg retrieval make Japan's publicly-funded egg freezing initiative a poor solution to the country's problem of population shrinkage.
ĎSafeí call? My thoughts on the latest mitochondrial replacement paper by Ted MorrowTed's BlogJune 14th, 2016A paper published by Nature discusses mitochondrial replacement but underplays the danger of "mitonuclear mismatching."
Testing, testing: Prenatal genetic screeningby Joe GibesTrinity International University June 10th, 2016Confusion and uncertainty surround both the accuracy of prenatal genetic screening and people's understanding of what PGS is.
The Politics of Womenís Eggsby Diane ToberUndarkJune 10th, 2016A California bill would allow researchers to obtain eggs by paying women to provide them, though little research exists on the procedure's long-term health impacts.
Displaying 1-10 of 1451  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760